Haagsma, C.J.

dr. C.J. Haagsma

Afspraak maken?

Aandachtsgebieden

  • Echografie van bewegingsapparaat
  • Geneesmiddelen

CV

  • 1997 e.v. Werkzaam in ZGT Almelo als reumatoloog
  • 1997 Registratie als reumatoloog
  • 1991 Registratie als internist
  • 1985 Arts-examen, K.U., Nijmegen

Nevenfuncties

Opleider reumatologie ZGT Voorzitter landelijke werkgroep echografie NVR Voorzitter geneesmiddelencommissie ZGT Lid medisch ethische toetsingscommissie

Wetenschappelijke publicaties en onderzoeken

  • Can baseline ultrasound results help to predict failure to achieve DAS28 remission after 1 year of tight control treatment in early RA patients?

    Cate DF ten, Jacobs JW, Swen WA, Hazes JW, Jager MH de , Basoski NM, Haagsma CJ.
    Arthritis Res Ther. 2018; 20(1):15..

    Publicatie openen
  • Verslag workshop echografische diagnostiek Giant Cell Arteritis/ grotevatenvasculitis

    Boumans D, Berendsen D, Haagsma CJ, Colin EM, Brouwer E.
    Ned. Tijdschr. Reum. 2018; 21(2):33-37.

    Publicatie openen
  • Limited value for ultrasonography in predicting flare in rheumatoid arthritis patients with low disease activity stopping TNF inhibitors

    Lamers-Karnebeek FB, Luime JJ, Cate DF ten , Teerenstra S, Swen NW, Haagsma CJ.
    Rheumatology (Oxford) 2017; :10.1093/rheumatology/kex184.

    Publicatie openen
  • Development of a web-based patient decision aid for initiating disease modifying anti-rheumatic drugs using user-centred design methods.

    Nota I, Melissant CH, Taal E, Vonkeman HE, Haagsma CJ, Laar MA van de .
    BMC Med Inform Decis Mak 2017; 17(1):51-.

    Publicatie openen
  • Evaluation of a patient decision aid for initiating disease modifying anti-rheumatic drugs

    Nota I, Drossaert CH, Taal E, Vonkeman HE, Haagsma CJ, Laar MA van de.
    Arthritis Res Ther 2016; 18(1):252.

    Publicatie openen
  • Comparison of two different dosages of intra-articular triamcinolone for the treatment of knee arthritis: results of a 12-week randomized, double-blind, controlled clinical trial

    Popma JW, Snel FW, Haagsma CJ, Brummelhuis-Visser P, Oldenhof HGJ, Palen J van der, Laar MA van de .
    Journal of Theumatol. 2015; :Accepted.

  • Black and white: alkaptonuria and gout

    Boumans D, Haagsma CJ.
    Rheumatology (Oxford) 2013; 52(9):1700.

    Publicatie openen
  • Role of ultrasonography in diagnosing early rheumatoid arthritis and remission of rheumatoid arthritis--a systematic review of the literature

    Cate DF ten, Luime JJ, Swen N, Gerards AH, Jager MH de, Basoski NM, Hazes JM, Haagsma CJ, Jacobs JW.
    Arthritis Res Ther 2013; 15(1):R4.

    Publicatie openen
  • Tenosynovitis caused by a pseudallescheria boydii infection and symptoms of reflex sympathetic dystrophy after a dog bite

    Ruinemans GMF, Haagsma CJ, Hendrix R.
    J Clin Rheumatol 2011; 17(7):363-364.

    Publicatie openen
  • Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study

    Vermeer M, Kuper HH, Hoekstra M, Haagsma CJ, Posthumus MD, Brus HL, Riel PL van, Laar MA van de.
    Arthritis Rheum 2011; 63(10):2865-72.

  • Corticosteroid injections reduce size of rheumatoid nodules.

    Baan H, Haagsma CJ, Laar MA van de.
    Clin Rheumatol. 2006; 25(1):21-3.

  • Longterm observational study of methotrexate use in a Dutch cohort of 1022 patients with rheumatoid arthritis.

    Hoekstra M, Laar MA de, Bernelot Moens HJ, Kruijsen MW, Haagsma CJ.
    J Rheumatol. 2003; 30(11):2325-9.

  • Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis.

    Hoekstra M, Ede AE van, Haagsma CJ, Laar MA van de, Huizinga TW, Kruijsen MW, Laan .
    Ann Rheum Dis. 2003; 62(5):423-6.

  • Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.

    Ede AE van, Laan RF, Blom HJ, Boers GH, Haagsma CJ, Thomas CM, Boo TM de, Putte van de.
    Rheumatology (Oxford). 2002; 41(6):658-65.

  • The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients.

    Ede AE van, Laan RF, Blom HJ, Huizinga TW, Haagsma CJ, Giesendorf BA, Boo TM de, Putte LB van de .
    Arthritis Rheum. 2001; 44(11):2525-30.

  • Pharmacotherapeutic combination strategies with disease-modifying antirheumatic drugs in established rheumatoid arthritis.

    Riel PL van, Haagsma CJ, Furst DE.
    Baillieres Best Pract Res Clin Rheumatol. 1999; 13(4):689-700. Review..

  • Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis.

    Haagsma CJ, Blom HJ, Riel PL van, Hof MA van 't, Giesendorf BA, Oppenraaij-Emmerzaal D van, Putte LB van de.
    Ann Rheum Dis. 1999; Feb;58(2):79-84.